Intestinal protein leakage in the acquired immunodeficiency syndrome

Journal of Clinical Gastroenterology

Volumn 25, Issue 2, 1997, Pages 426-428

  Becker, Klaus ^a   Lindner, Claudia ^a   Frieling, Thomas ^a   Niederau, Christoph ^a   Reinauer, Hans ^a   Häussinger, Dieter ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

1; Acquired immunodeficiency syndrome; Antitrypsin; Chronic inflammatory bowel disease; Human immunodeficiency virus; Hypoalbuminemia; Intestinal permeability; Intestinal protein loss; Wasting syndrome

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENTERITIS; FECES LEVEL; FEMALE; HUMAN; HYPOALBUMINEMIA; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN METABOLISM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALPHA 1-ANTITRYPSIN; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; MALE; MIDDLE AGED; WASTING SYNDROME;

EID: 0030717701     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199709000-00005     Document Type: Article

References (13)

1. Laine L, Garcia F, McGilligan K, Malinko A, Sinatra FR, Thomas DW. Protein-losing enteropathy and hypoalbuminemia in AIDS. AIDS 1993;7:837-40.
2. 1 antitrypsin as a marker of gastrointestinal disease in HIV antibody positive individuals. Gut 1996;38:206-10.
3. Crossley JR, Elliott RB. Simple method for diagnosing protein-losing enteropathies. BMJ 1977;1:428-9.
4. 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology 1981;81: 777-80.
5. 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut 1983;24:718-23.
6. 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology 1985;89:13-18.
7. 1-Antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology 1990;99:1380-7.
8. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-4.
9. Rachmilewitz D. Coated mesalazine (5-aminosalicyl acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ 1989;298:82-6.
10. 1-antitrypsine. Lab Med 1989;13:254-8.
11. Stufler MHM, Ewe K, Gierlasinski B, Prün H, Zutt M. Elevated serum α-1-antitrypsin does not cause increased fecal α-1-AT excretion in patients with normal bowel. German Journal of Gastroenterology 1991;29:11-15.
12. Bjarnason I. Clinical significance of increased intestinal permeability in man [Abstract]. German Journal of Gastroenterology 1995;33:561.
13. Ullrich R, Zeitz M, Heise W, L'age M, Höffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med 1989;111:15-21.